Business & Investments

Visiopharm Expands Into the Benelux Region with New Office and Leadership

Hørsholm, DK (PRWEB) September 29, 2014

Benelux (Belgium, Netherlands, and Luxembourg) is an important hot-spot for the adoption of Digital Pathology in routine diagnostics in Europe. Over the last few years, Visiopharm has tested, validated, and implemented a CE IVD-marked Laboratory Information System (LIS) driven image analysis software for automating key aspects of the diagnostic workflow in leading Scandinavian pathology labs. There has simultaneously been a growing interest in these solutions throughout Benelux.

In order to support customers in Benelux, Visiopharm has established a branch office in the Netherlands. Mr. Jan Pijnenburg has been appointed as Sales Director, and will start on October 1, 2014. “We are very impressed with Mr. Jan Pijnenburg, and his deep and profound understanding of the clinical Digital Pathology field, including how it has changed over the recent years. He has a unique background with a practical and educational foundation in pathology, combined with a long and successful track-record at Dako and at Thermo-Fisher. This makes Jan the ideal partner to guide pathology labs safely through the implementation of Digital Pathology efficiently into their workflows, and an important addition to Visiopharm’s interdisciplinary team of experts,” says Michael Grunkin, CEO of Visiopharm.

“In order for Digital Pathology to become widely accepted and adopted in routine diagnostics it really has to solve two important problems: It has to make pathologists more productive and it must enable pathologists to provide data with a higher quality than is currently possible. Visiopharm has the innovation, vision, and technical capabilities required for accomplishing these aims. Plus, Visiopharm has taken the necessary steps to obtain robust clinical documentation and regulatory clearance for their system. I am excited about the opportunity to help pathologists in Benelux benefit from these new technical advances in Digital Pathology,” says Jan Pijnenburg.

Visiopharm is the leading Digital Pathology image analysis company to combine technical depth and sophistication with scientific and regulatory rigor for Clinical Cancer Diagnostics and Research.

About Visiopharm

Over the past 13 years, Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, clinical researchers, and academic researchers all over the world. Recently, Visiopharm has expanded to include a robust solution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Our software is featured in over 700 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras. Visiopharm has grown into an international business with over 475 customers in more than 30 countries. Our growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.